GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 32,667 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GSK
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	8,341	7,980	7,983	8,490	18,079	20,534	21,212	21,413	19,977	21,655	23,218	22,739	24,352	28,368	28,392	27,387	26,431	26,505	23,006	23,923	27,889	30,186	30,821	33,754	24,354	24,696	29,324	30,328	31,376	32,667
Cost of Revenue	–	–	1,545	4,334	3,962	4,440	4,609	4,538	4,358	4,763	5,009	5,211	6,415	7,380	7,898	7,648	7,925	8,585	7,323	8,853	9,290	10,342	10,241	11,863	7,929	8,163	9,554	8,565	9,048	9,017
Gross Profit	8,341	7,980	6,438	4,156	14,117	16,094	16,603	16,875	15,619	16,892	18,209	17,528	17,937	20,988	20,494	19,739	18,506	17,920	15,683	15,070	18,599	19,844	20,580	21,891	16,425	16,533	19,770	21,763	22,328	23,650
Research & Development	1,161	1,148	1,163	1,269	2,526	2,561	2,900	2,787	2,903	3,135	3,456	3,240	3,681	4,106	4,457	4,009	3,979	3,923	3,450	3,560	3,628	4,476	3,893	4,568	4,793	5,019	5,488	6,223	6,401	7,525
Selling, General & Administrative	–	–	–	–	13,916	7,467	8,041	7,571	7,198	7,248	7,255	6,824	7,656	9,592	12,747	8,510	8,789	8,480	8,246	9,232	9,366	9,672	9,915	11,402	7,437	7,070	8,372	9,385	11,015	9,088
Total Operating Expenses	5,209	5,158	3,755	1,531	9,388	9,991	11,052	10,492	9,866	16,528	10,403	9,589	10,796	12,563	16,711	11,932	11,206	10,892	12,086	4,748	16,001	15,757	15,097	14,930	10,446	12,176	13,337	15,018	18,307	15,312
Operating Income	3,132	2,822	2,683	2,625	4,729	6,103	5,551	6,383	5,260	6,865	7,186	7,939	7,141	8,425	3,783	7,807	7,300	7,028	3,597	10,322	2,598	4,087	5,483	6,961	5,979	4,357	6,433	6,745	4,021	8,338
Interest Expense	276	227	202	206	317	1,149	206	161	362	451	352	315	843	783	765	742	735	767	696	757	736	734	744	912	892	784	856	775	658	687
Pre-Tax Income	2,964	2,686	2,671	2,575	6,029	6,085	5,506	6,321	5,448	7,099	7,471	7,537	6,659	7,891	3,157	7,698	6,600	6,647	2,968	10,526	1,939	3,525	4,800	6,221	5,170	3,599	5,628	6,064	3,477	7,401
Income Tax Expense	933	819	815	746	1,747	1,650	1,461	1,737	1,674	2,020	2,204	2,155	1,947	2,222	1,304	2,240	1,922	1,019	137	2,154	877	1,356	754	953	67	83	707	756	526	1,112
Net Income	1,997	1,850	1,836	1,811	4,162	3,100	3,935	4,478	3,906	4,688	5,387	5,219	4,602	5,531	1,634	5,261	4,499	5,436	2,756	8,422	912	1,532	3,623	4,645	5,749	4,385	14,956	4,928	2,575	5,716
EBITDA	3,650	3,286	3,231	3,209	7,108	6,916	6,536	7,242	6,612	1,268	8,763	9,224	8,733	10,236	5,621	9,877	8,805	8,801	5,155	12,891	4,430	6,184	7,350	9,220	8,067	6,485	8,601	9,083	6,668	10,402

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings